Support for an association between mismatch negativity and social functioning in schizophrenia
This approach means taking your total weekly dose and breaking it into smaller, more frequent injections instead of one single shot

A lower ratio means more stable levels, which theoretically translates to: Consistent therapeutic effect: Steady drug levels maintain continuous receptor activation Reduced side effects: Lower peak concentrations minimize adverse reactions Better tolerability: Gradual exposure allows physiological adaptation Mathematical modeling shows: Weekly dosing P/T ratio: ~3.5-4.0 Twice-weekly dosing P/T ratio: ~2.0-2.5 Daily dosing P/T ratio: ~1.2-1.5 Peak reduction with split dosing: 28-38% Trough increase with split dosing: 15-25% The Triple Agonist Complexity Retatrutide's unique triple mechanism adds layers of complexity to microdosing considerations: GLP-1 receptors: Rapid desensitization may benefit from lower, more frequent activation for sustained weight-loss effects GIP receptors: Different tissue distribution and kinetics than GLP-1 Glucagon receptors: Energy expenditure effects may vary with dosing pattern Receptor balance: Unknown how split dosing affects the ratio of receptor activation Lessons from Established Peptide Therapies Insulin: The Original Microdosing Success Insulin therapy provides the strongest precedent for peptide microdosing: Traditional Approach: NPH insulin twice daily High P/T ratios Frequent hypoglycemia Poor glycemic control Modern Microdosing: Basal-bolus regimens Continuous infusion pumps Stable glucose levels Reduced complications The shift from infrequent large doses to frequent small doses dramatically improved diabetes outcomes

Eli Lilly has strong financial incentive to make the medication accessible, because broader adoption drives revenue far more effectively than keeping prices artificially high and limiting the patient pool
Additionally, this supplement contains herbal extracts that may interact with certain medications
#ObesityManagement #GLP1 #OralSemaglutide #Pharmacotherapy #ClinicalPharmacy #SCOPECertified #BCPS #M42 #UAEHealthcare #WeightLossInnovation To view or add a comment, sign in 17,263 followers